First Posted,NCT Number,Title,Start Date,Completion Date,Sponsor/Collaborators,Company Name
"May 19, 2020",NCT04394247,"Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy","June 30, 2020","December 31, 2020",Pfizer,Syapse
